Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
15 Oct 2024 |
CS01 |
Confirmation statement made on 13 October 2024 with updates
|
|
|
09 Oct 2024 |
AA |
Accounts for a small company made up to 31 December 2023
|
|
|
06 Nov 2023 |
PSC08 |
Notification of a person with significant control statement
|
|
|
06 Nov 2023 |
MA |
Memorandum and Articles of Association
|
|
|
06 Nov 2023 |
RESOLUTIONS |
Resolutions
-
RES12 ‐
Resolution of varying share rights or name
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
06 Nov 2023 |
SH08 |
Change of share class name or designation
|
|
|
06 Nov 2023 |
SH08 |
Change of share class name or designation
|
|
|
27 Oct 2023 |
AA01 |
Current accounting period extended from 31 October 2023 to 31 December 2023
|
|
|
27 Oct 2023 |
PSC07 |
Cessation of Clevexel Pharma as a person with significant control on 14 October 2023
|
|
|
27 Oct 2023 |
PSC02 |
Notification of Clevexel Pharma as a person with significant control on 1 August 2023
|
|
|
27 Oct 2023 |
PSC07 |
Cessation of Medicxi Iii Lp as a person with significant control on 14 October 2023
|
|
|
27 Oct 2023 |
TM01 |
Termination of appointment of Francesco De Rubertis as a director on 14 October 2023
|
|
|
27 Oct 2023 |
TM01 |
Termination of appointment of Christian Bloy as a director on 14 October 2023
|
|
|
13 Oct 2023 |
CS01 |
Confirmation statement made on 13 October 2023 with updates
|
|
|
12 Sep 2023 |
SH01 |
Statement of capital following an allotment of shares on 12 September 2023
|
|
|
12 Sep 2023 |
PSC07 |
Cessation of Clevexel Pharma as a person with significant control on 1 August 2023
|
|
|
24 Jul 2023 |
AA |
Accounts for a small company made up to 31 October 2022
|
|
|
11 May 2023 |
TM01 |
Termination of appointment of Richard Michael Lee as a director on 10 May 2023
|
|
|
12 Dec 2022 |
TM01 |
Termination of appointment of Nicholas Alexander Williams as a director on 8 December 2022
|
|
|
12 Dec 2022 |
AP01 |
Appointment of Francesco De Rubertis as a director on 8 December 2022
|
|
|
25 Oct 2022 |
CS01 |
Confirmation statement made on 13 October 2022 with updates
|
|
|
14 Sep 2022 |
PSC02 |
Notification of Clevexel Pharma as a person with significant control on 20 December 2021
|
|
|
31 Jan 2022 |
RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 29 December 2021
|
|
|
21 Jan 2022 |
SH01 |
Statement of capital following an allotment of shares on 29 December 2021
-
ANNOTATION
Clarification a second filed SH01 was registered on 31/01/22
|
|
|
18 Jan 2022 |
SH08 |
Change of share class name or designation
|
|